In our study, the combination of THD and PTX (T + LD-RTX) considerably increased peripheral blood CD16+CD56+CD3− NK cell counts in patients with steroid-refractory or steroid-dependent ITP, compared to monotherapy. The gene discussed is NCAM1; the disease is autoimmune thrombocytopenic purpura.